INTRODUCTION:
The COVID-19 pandemic, caused by the highly contagious SARS-CoV-2 virus, has prompted an urgent global response to develop vaccines, treatments, and effective diagnostic methods. SARS-CoV-2, a member of the Coronaviridae family, was first identified in Wuhan, China, in December 2019 and has since caused a global pandemic. Unlike its predecessors, SARS-CoV and MERS-CoV, SARS-CoV-2 is highly contagious and has led to significant morbidity and mortality worldwide.
The disease manifests with symptoms such as fever, cough, fatigue, and respiratory distress. Despite extensive research efforts, no specific antiviral treatment has been universally accepted for COVID-19.1
It stands out due to its sensitivity and specificity in analyzing complex biological samples. GC-MS facilitates the identification of volatile organic compounds (VOCs) that may serve as biomarkers for disease detection or therapeutic monitoring.2
One crucial aspect of COVID-19 research is the development of effective therapeutics and vaccines. Traditional and modern techniques are used to identify components of herbal drugs, plant-based compounds, and synthetic antivirals. Among the most promising analytical tools for drug research is Gas Chromatography-Mass Spectrometry (GC-MS), stands out due to its sensitivity and specificity in analyzing complex biological samples. GC-MS facilitates the identification of volatile organic compounds (VOCs) that may serve as biomarkers for disease detection or therapeutic monitoring, and a technique that plays a key role in analyzing SARS-CoV-2 drugs in biological samples. This article explores the significant role of GC-MS in drug analysis and its broader applications in SARS-CoV-2 research.3
What is GC-MS?
Gas Chromatography-Mass Spectrometry (GC-MS) is a powerful analytical technique that combines two methods: Gas Chromatography (GC) and Mass Spectrometry (MS). GC is used to separate compounds in a sample based on their volatility, while MS identifies and quantifies the compounds by analyzing their mass-to-charge ratio. Together, GC-MS is a highly sensitive and versatile tool that can detect even trace amounts of volatile and semi-volatile organic compounds in complex biological samples.4
GC-MS is widely used in diverse fields, including forensic science, environmental monitoring, and food safety. In the context of SARS-CoV-2, GC-MS is indispensable for drug development, diagnostics, and biomarker discovery, especially for understanding how antiviral drugs behave in the body and identifying new therapeutic targets.4
1. Forensic Science
· Crime Scene Investigation: GC-MS is employed to analyze samples collected from crime scenes, such as blood or tissue, to identify substances that can link suspects to criminal activities. It can detect drugs, poisons, and other chemicals that may indicate foul play or the cause of death.5
· Fire Investigation: The technique is crucial in forensic investigations involving fires. GC-MS can identify accelerants in fire debris, helping investigators determine the origin and cause of a fire.5
2. Environmental Monitoring:
· Contaminant Detection: GC-MS is used to monitor environmental pollutants in air, water, and soil. It can detect volatile organic compounds (VOCs), pesticides, and other hazardous substances, making it essential for environmental compliance and cleanup efforts.6
· Pesticide Analysis: The method is widely applied in agricultural studies to ensure that food products are free from harmful pesticide residues
3. Pharmaceutical Industry:
· Drug Testing: GC-MS plays a vital role in toxicology by identifying drugs and their metabolites in biological samples like urine and blood. This application is critical for both clinical diagnostics and anti-doping tests in sports.7
· Quality Control: In pharmaceuticals, GC-MS is used to analyze active pharmaceutical ingredients (APIs) for purity and to identify impurities, ensuring product safety and efficacy.
4. Food and Beverage Analysis:
· Safety and Quality Assurance: GC-MS is integral to the food industry for analyzing food products for contaminants, such as pesticides or adulterants. It also helps characterize flavor compounds and assess the authenticity of food products.8
· Flavor Profile Analysis: The technique is employed to analyze the aromatic compounds present in beverages like wine or spirits, contributing to quality control and product development.
5. Chemical Engineering:
· Composition Analysis: GC-MS is utilized for analyzing complex mixtures in chemical engineering applications, such as determining the composition of biofuels or petrochemical products.9
· Material Characterization: The technique aids in identifying components within smart materials or polymers, providing insights into their properties and performance
6. Space Exploration:
· Sample Analysis from Space Missions: GC-MS has been used in space missions to analyze atmospheric samples from planets like Mars and Venus. This application helps scientists understand the chemical composition of extraterrestrial environments
7. Metabolomics:
· Biological Research: In metabolomics studies, GC-MS is employed to analyze metabolites in biological samples, aiding in the understanding of metabolic pathways and disease mechanisms. This application is particularly relevant in research related to conditions like diabetes or cancer.
Fig- 01 Schematic Representation of GC-MS
GC-MS in Analyzing SARS-CoV-2 Drugs in Biological Samples:
One of the key challenges in managing the COVID-19 pandemic has been the rapid and accurate detection of the virus. Traditional diagnostic methods, like the RT-PCR test, require invasive sample collection and can be time-consuming. In contrast, GC-MS offers a non-invasive, highly sensitive alternative for detecting volatile organic compounds (VOCs) in exhaled breath, saliva, or nasopharyngeal swabs, which can indicate the presence of the virus.9
For example, a study published in 2021 demonstrated that GC-MS could analyze exhaled breath samples to identify specific VOCs associated with SARS-CoV-2 infection. These VOCs include acetone, ethanol, and isopropanol, which have been found in higher concentrations in the breath of COVID-19 patients compared to healthy individuals. The GC-MS analysis of these biomarkers could help distinguish between PCR-positive and negative individuals, even in asymptomatic carriers, offering a rapid and non-invasive diagnostic method.
Real-World Example:
A research team in Italy used GC-MS to analyze the breath of patients suspected of having COVID-19. They identified a specific pattern of VOCs that could differentiate infected individuals from healthy controls. The VOC signature was found to correlate strongly with PCR test results, highlighting the potential of GC-MS as a complementary diagnostic tool.9
One of the most important roles of GC-MS in COVID-19 research is the analysis of drugs used to treat the virus. For example, drugs like hydroxychloroquine and remdesivir have been widely studied for their antiviral properties against SARS-CoV-2. GC-MS can be used to measure the concentration of these drugs in biological samples like serum, urine, and plasma, ensuring their efficacy and safety. By identifying drug metabolites and monitoring their concentrations, GC-MS helps optimize dosing regimens, minimizing toxicity and maximizing therapeutic benefits.10
For instance, hydroxychloroquine, which has been explored as a treatment for COVID-19, requires careful monitoring of blood concentrations to ensure it stays within therapeutic levels. Studies have used GC-MS to track hydroxychloroquine levels in plasma and serum, revealing important data on its pharmacokinetics and helping to fine-tune treatment protocols.
Example1: Remdesivir Pharmacokinetics
GC-MS has been used to study the pharmacokinetics of remdesivir, an antiviral
drug that has received emergency use authorization for treating COVID-19. In
clinical trials, GC-MS helped measure remdesivir’s metabolites in serum
samples, providing valuable information on how the drug is absorbed,
distributed, and eliminated from the body. By accurately quantifying drug
levels, GC-MS enabled researchers to determine the optimal dose and
administration schedule, which is crucial in avoiding side effects and ensuring
efficacy.
Example 2: Chloroquine in Serum and Urine
Another significant application of GC-MS is in the analysis of chloroquine and
its metabolite desethylchloroquine. These drugs have been used in the treatment
of COVID-19, and their safe use requires understanding how they interact with
the body. Using GC-MS, researchers have been able to detect trace levels of
chloroquine in urine and serum samples, providing crucial data for dose
adjustments and monitoring for toxicity. The ability to detect and quantify
these drugs at such low levels is vital in ensuring that patients receive the
correct therapeutic dose.11
GC-MS in Drug Monitoring and Toxicity Studies
In addition to helping develop new treatments, GC-MS is essential in monitoring the safety and effectiveness of drugs. For SARS-CoV-2 treatments, including antivirals and immune modulators, it’s critical to ensure that patients receive the correct dose and to monitor for any adverse drug reactions or toxicity.
GC-MS is particularly useful in monitoring the presence of drugs in biological fluids like blood, serum, or urine. For instance, hydroxychloroquine has been studied for its potential use in treating COVID-19, and GC-MS has been employed to measure its levels in patients to ensure they remain within safe therapeutic ranges.12
Real-World Example: In one study, researchers used GC-MS to monitor levels of chloroquine in the blood of COVID-19 patients. The results indicated that patients who received higher doses of chloroquine had elevated drug concentrations in their blood, which could lead to toxicity. This highlighted the importance of using GC-MS to carefully regulate drug dosing and prevent adverse effects.
GC-MS in SARS-CoV-2 Diagnostics: Exhaled Breath Biomarkers:
In addition to drug analysis, GC-MS has found applications in diagnosing COVID-19. One innovative approach is analyzing exhaled breath samples for volatile organic compounds (VOCs) that may be indicative of SARS-CoV-2 infection. VOCs are small molecules that are produced during metabolic processes and can be detected in the breath of infected individuals. GC-MS is highly effective in identifying and quantifying these VOCs, offering a non-invasive, rapid diagnostic method for COVID-19.13
A 2021 study demonstrated that GC-MS could analyze breath samples to detect VOC patterns associated with SARS-CoV-2. The study found that certain VOCs were significantly elevated in COVID-19 patients, distinguishing them from healthy individuals and those with other respiratory infections. These findings suggest that GC-MS could play a vital role in developing a breathalyzer-like device for quick and easy COVID-19 detection.
Example 3: Exhaled Breath Biomarker Discovery
In a study conducted by researchers in Germany, GC-MS was employed to analyze
the breath of COVID-19 patients. They identified a distinct VOC signature that
could differentiate infected individuals from healthy controls with a high
degree of accuracy. This study exemplifies how GC-MS can aid in the early
detection of COVID-19, even in asymptomatic carriers, providing a promising
tool for large-scale screening in airports, hospitals, and other public spaces.
GC-MS in Pharmacogenomics and Antiviral Drug Discovery:
GC-MS also plays a critical role in the broader research landscape of antiviral drug discovery for SARS-CoV-2. By analyzing metabolomic data, GC-MS allows scientists to track how the virus affects host cell metabolism and to identify metabolic pathways that could serve as potential targets for new drugs. By studying the metabolites involved in SARS-CoV-2 infection, GC-MS can help identify new drug candidates or drug repurposing opportunities.
For example, favipiravir, an antiviral that has shown promise in treating COVID-19, has been studied using GC-MS to better understand its metabolism in serum and plasma. Such data helps researchers assess the drug’s effectiveness and refine its use in different patient populations.13
GC-MS in Forensics and Public Health Applications:
Beyond its use in drug analysis, GC-MS is also critical in the broader public health response to the pandemic. The technique is used for forensic toxicology to detect the presence of drugs of abuse or poisons in biological samples, which can be relevant in investigating cases where drug toxicity may be a factor in a patient's condition. In environmental monitoring, GC-MS is used to detect chemical contaminants that may be linked to SARS-CoV-2 spread or environmental degradation.14
For example, GC-MS is widely used in forensic investigations to analyze fire debris, detect explosive materials, and link criminals to specific drugs or substances. This same methodology is applied in the analysis of COVID-19 patients, aiding public health authorities in monitoring disease transmission and managing the pandemic more effectively.
CONCLUSION:
Gas Chromatography-Mass Spectrometry (GC-MS) is proving to be an indispensable tool in the fight against COVID-19. From detecting viral biomarkers in breath samples to monitoring drug concentrations and understanding the pharmacokinetics of antiviral agents, GC-MS has revolutionized many aspects of SARS-CoV-2 research. Its sensitivity, precision, and ability to analyze complex biological samples make it a crucial tool for diagnosing the disease, developing treatments, and ensuring patient safety.
As the world continues to fight the COVID-19 pandemic and prepares for future outbreaks, GC-MS will remain at the forefront of diagnostic and therapeutic research. Whether it’s detecting exhaled breath biomarkers for rapid, non-invasive screening or analyzing new antiviral drugs, GC-MS offers a robust, reliable method to support the global response to infectious diseases.
In the future, we can expect GC-MS to become even more integral to personalized medicine, disease prevention, and public health strategies, helping researchers and clinicians stay one step ahead of emerging health threats.
REFERENCES:
1. Chen X, Gu X, Yang J, Jiang Z, Deng J. Gas Chromatography–Mass Spectrometry Technology: Application in the Study of Inflammatory Mechanism in COVID-19 Patients. Chromatographia. 2023 Feb; 86(2): 175-83.
2. Manisha Rokade, Pradnya Khandagale. Coronavirus Disease: A Review of a New Threat to Public Health. Asian J. Pharm. Res. 2020; 10(3): 241-244.
3. Ganesh Bharskar, Someshwar Mankar, Suhas Siddheshwar. Analytical Methods for Estimation of Curcumin in Bulk, Pharmaceutical Formulation and in Biological Samples. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):142-8.
4. Hariprasath Pandurangan. Middle East Respiratory Syndrome (MERS) a Threat to Asian Countries. Asian J. Nursing Education and Research. 2018; 8(3): 375-378.
5. Xie Z, Morris JD, Pan J, Cooke EA, Sutaria SR, Balcom D, Marimuthu S, Parrish LW, Aliesky H, Huang JJ, Rai SN. Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breath. Scientific Reports. 2024 Jun 24;14(1):14568.
6. Yuan ZC, Hu B. Mass spectrometry-based human breath analysis: towards COVID-19 diagnosis and research. Journal of analysis and testing. 2021; Dec; 5(4): 287-97.
7. Pumila Singh, Divya Sharma, Varsha Singh, Sheila Kumari, Arjun Singh, Hema Jain. Management of Non-hospitalized patients with Acute SARS-CoV-2 (COVID-19) viral infection in among human adult population. Asian Journal of Management. 2023; 14(4): 227-2.
8. P. Lova Kumar, B. Sreedhar Reddy, V. Tulasi Das. Mediating Effect of Job Resources on Psychological Wellbeing and Employee Engagement- Centric to Public Sector Telecom in Pandemic, India. Asian Journal of Management. 2023;14(3):216-4.
9. Patel DV, Patel BD, Patel NK, Sheth NR, Dabhi MR, Dudhrejiya AV. Quality improvement methodologies in pharmaceutical manufacturing. Asian Journal of Management. 2010;1(1):1-3.
10. Balaji EV, Selvan A, Srinivasan A, Nandhini S. Punica granatum root (s): Phytocompounds analysis, Anti-oxidant and Anti-microbial activity. Asian Journal of Pharmaceutical Analysis. 2019;9(3):123-7.
11. Pawar K, Sankpal P, Patil S, Patil P, Pawar A, Shinde P. Applications of GC-MS used in Herbal plants. Asian Journal of Pharmaceutical Analysis. 2022;12(1):53-5.
12. Shravya D, Archana J. A New Validated UV Spectroscopic Method for the Estimation of Favipiravir, an anti-influenza drug in COVID 19. Asian Journal of Pharmaceutical Analysis. 2024;14(2):65-8.
13. Sri KB, Shailaja G, Mogili S. Two dimensional gas chromatography-A review. Asian Journal of Pharmaceutical Analysis. 2021; 11(4): 293-6.
14. Ismail NZ, Adebayo IA, Mohamad Zain NN, Arsad H. Molecular docking of compounds from Clinacanthus nutans extract detected by GC-MS analysis with the SARS-CoV-2 main protease and ACE2 protein. Natural Product Research. 2022 Jun 2;36(11):2848-52.
15. Alam R, Imon RR, Talukder ME, Akhter S, Hossain MA, Ahammad F, Rahman MM. GC-MS analysis of phytoconstituents from Ruelliaprostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2. Rsc Advances. 2021;11(63):40120-35.
16. S Shyam Prasad, Pratikshya Praharaj. Indian consumers’ behaviour during COVID 19: An Exploratory Study. Asian Journal of Management. 2021; 12(2):215-0.
17. Telavane SA, Kothari S, Lokhande MV. Method of validation for residual solvents in bisoprolol fumarate by GC technique. Asian Journal of Pharmaceutical Research. 2021;11(3):147-55.
18. Nishu Ayedee, Anuj Kumar. Indian Education System and growing number of online Conferences: Scenario under COVID-19. Asian Journal of Management. 2020;11(4)395-401.
19. Gurvishal Sinha. The vista of Pandemic in the world and its adaptation by Society: Statistical significant precautions on COVID. Asian Journal of Management. 2020;11(4):453-456.
20. Cijo John, Priyankar Ghosh, K.M. Varshney, S.K. Shukla, S.Satyanarayana. High Performance Liquid Chromatography Method for the Determination of Dextropropoxyphene in Hair and Nail. Asian J. Research Chem. 5(8): August, 2012; Page 966-971.
21. Nikhat Farhana, Thouheed Ansari, Moid Ansari. Sars-CoV-2leader-RNA-primed Transcription and RNA-Splicing prevention, control and Treatment. Asian J. Research Chem. 2020; 13(4):291-298.
22. Gokool VA, Crespo-Cajigas J, Mallikarjun A, Collins A, Kane SA, Plymouth V, Nguyen E, Abella BS, Holness HK, Furton KG, Johnson AT. The use of biological sensors and instrumental analysis to discriminate COVID-19 odor signatures. Biosensors. 2022 Nov 11;12(11):1003.
23. Ibrahim W, Cordell RL, Wilde MJ, Richardson M, Carr L, Dasi AS, Hargadon B, Free RC, Monks PS, Brightling CE, Greening NJ. Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry. ERJ open research. 2021 Jul 1; 7(3).
24. Myers R, Ruskiewicz D, Meister A, Sukhinder AK, Bartolomeu C, Thomas P, Lam S. Breath collection protocol for SARS-CoV-2 testing in an ambulatory setting. Journal of Breath Research. 2022 Apr 1;16(2):027105.
25. Chavda VP, Valu DD, Parikh PK, Tiwari N, Chhipa AS, Shukla S, Patel SS, Balar PC, Paiva-Santos AC, Patravale V. Conventional and novel diagnostic tools for the diagnosis of emerging SARS-CoV-2 variants. Vaccines. 2023 Feb 6;11(2):374.
|
Received on 16.08.2024 Revised on 05.09.2024 Accepted on 05.10.2024 Published on 22.10.2024 Available online from October 31, 2024 Asian J. Research Chem.2024; 17(5):296-300. DOI: 10.52711/0974-4150.2024.00051 ©AandV Publications All Right Reserved
|
|
|
This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License. Creative Commons License. |
|
